Amgen, Inc. - Company Profile and SWOT Analysis
Summary
Amgen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Amgen, Inc. (Amgen or 'the company') is a developer, manufacturer, and marketer of human therapeutics. The company develops products mainly in the areas of oncology/hematology, cardiovascular, neuroscience, bone health, and inflammation. The company's product portfolio includes Prolia , XGEVA, EVENITY, Repatha, Aranesp, and KYPROLIS. It sells its products through pharmaceutical wholesale distributors and through direct-to-consumer channels, including print, online media, and television. Amgen has business presence across the US, Europe, Latin America, the Middle East, and Asia Pacific. The company is headquartered in Thousand Oaks, California, the US.
Scope
- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Amgen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Amgen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Amgen, Inc.'s business structure, strategy and prospects.
- Company Snapshot
- Amgen, Inc.: Company Overview
- Amgen, Inc.: Overview and Key Facts
- Amgen, Inc.: Overview
- Amgen, Inc.: Key Facts
- Amgen, Inc.: Key Employees
- Amgen, Inc.: Key Employee Biographies
- Amgen, Inc.: Major Products and Services
- Amgen, Inc.: Company History
- Amgen, Inc.: Management Statement
- Amgen, Inc.: Locations and Subsidiaries
- Amgen, Inc.: Key Competitors
- Amgen, Inc.: Company Analysis
- Amgen, Inc.: Business Description
- Amgen, Inc.: SWOT Analysis
- Amgen, Inc.: SWOT Overview
- Amgen, Inc.: Strengths
- Amgen, Inc.: Weaknesses
- Amgen, Inc.: Opportunities
- Amgen, Inc.: Threats
- Amgen, Inc.: Corporate Financial Deals Activity
- Amgen, Inc.: Financial Deals Overview
- Amgen, Inc.: Targets and Partners
- Amgen, Inc.: Top Deals 2021 - 2025YTD*
- Amgen, Inc.: Advisors
- Amgen, Inc.: Top Legal Advisors
- Amgen, Inc.: Top Financial Advisors
- Amgen, Inc.: Mergers and Acquisitions
- Amgen, Inc.: Corporate Venturing
- Amgen, Inc.: Capital Raising
- Amgen, Inc.: Partnership
- Amgen, Inc.: Divestments
- Amgen, Inc.: Recent Developments
- Amgen, Inc.: News and Events Summary
- Amgen, Inc.: Business Expansion
- Amgen, Inc.: Contracts
- Amgen, Inc.: Corporate Governance
- Amgen, Inc.: Financial Deals
- Amgen, Inc.: Financial Performance
- Amgen, Inc.: Market Developments
- Amgen, Inc.: Regulatory and Legal Events
- Amgen, Inc.: Research & Development
- Amgen, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Amgen, Inc.: Key Facts
- Table 2: Amgen, Inc.: Key Employees
- Table 3: Amgen, Inc.: Company History
- Table 4: Amgen, Inc.: Locations and Subsidiaries
- Table 5: Amgen, Inc.: Key Competitors
- Table 6: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
- Table 9: Amgen, Inc.: Targets and Partners
- Table 10: Amgen, Inc.: Top Deals 2021 - 2025YTD*
- Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 13: Amgen, Inc.: M&A Volume and Value Trend (2021 - YTD*2025)
- Table 14: Amgen, Inc.: M&A Activity by Geography (2021 - YTD*2025)
- Table 15: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
- Table 16: Amgen, Inc.: Corporate Venturing by Geography (2021 - YTD*2025)
- Table 17: Amgen, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025)
- Table 18: Amgen, Inc.: Capital Raising by Deal Type (2021 - YTD*2025)
- Table 19: Amgen, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
- Table 20: Amgen, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
- Table 21: Amgen, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025)
- Table 22: Amgen, Inc.: Divestments by Geography (2021 - YTD*2025)
- Table 23: Amgen, Inc.: News and Events Summary
- Table 24: Amgen, Inc.: Business Expansion
- Table 25: Amgen, Inc.: Contracts
- Table 26: Amgen, Inc.: Corporate Governance
- Table 27: Amgen, Inc.: Financial Deals
- Table 28: Amgen, Inc.: Financial Performance
- Table 29: Amgen, Inc.: Market Developments
- Table 30: Amgen, Inc.: Regulatory and Legal Events
- Table 31: Amgen, Inc.: Research & Development
- Table 32: Amgen, Inc.: Strategy and Operations
- List of Figures
- Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Amgen, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Figure 3: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 4: Amgen, Inc.: M&A Volume and Value Trend (2021 - YTD*2025)
- Figure 5: Amgen, Inc.: M&A Activity by Geography (2021 - YTD*2025)
- Figure 6: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
- Figure 7: Amgen, Inc.: Corporate Venturing by Geography (2021 - YTD*2025)
- Figure 8: Amgen, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025)
- Figure 9: Amgen, Inc.: Capital Raising by Deal Type (2021 - YTD*2025)
- Figure 10: Amgen, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
- Figure 11: Amgen, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
- Figure 12: Amgen, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025)
- Figure 13: Amgen, Inc.: Divestments by Geography (2021 - YTD*2025)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook